A - Agilent Technologies, Inc.
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $1.37
|
Rev Est: $1.8B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$166.36
DETAILS
HIGH:
$180.00
LOW:
$130.00
MEDIAN:
$165.00
CONSENSUS:
$166.36
UPSIDE:
33.73%
Market Cap:
35.27B
Volume:
2,729,601
Avg Volume:
2,114,938
52 Week Range:
96.43-160.27
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
1.30
Last Dividend:
$1.00
Exchange:
NYSE
Country:
US
Employees:
17,900
IPO Date:
1999-11-18
EPS (TTM):
4.59
P/E Ratio:
31.79
Revenue (TTM):
6.95B
Total Assets:
12.73B
Total Debt:
3.35B
Cash & Equiv:
1.79B
Rev Growth (5Y):
5.4%
EPS Growth (5Y):
14.5%
FCF Growth (5Y):
7.5%
ROCE:
14.9%
Debt/Equity:
0.50
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-24 | $1.59 | $1.58 | +0.4% | $1.8B | $1.8B | +0.4% |
| 2025-08-27 | $1.37 | $1.37 | 0.0% | $1.7B | $1.7B | +3.2% |
| 2025-05-28 | $1.31 | $1.26 | +4.0% | $1.7B | $1.6B | +2.5% |
| 2025-02-26 | $1.31 | $1.28 | +2.3% | $1.7B | $1.7B | +0.7% |
| 2024-11-25 | $1.46 | $1.41 | +3.5% | $1.7B | $1.7B | +1.7% |
| 2024-08-21 | $1.32 | $1.26 | +4.8% | $1.6B | $1.6B | +1.3% |
| 2024-05-29 | $1.22 | $1.19 | +2.5% | $1.6B | $1.6B | -0.6% |
| 2024-02-27 | $1.29 | $1.22 | +5.7% | $1.7B | $1.6B | +4.4% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.95B | 6.51B | 6.83B | 6.85B | 6.32B | 5.34B | 5.16B | 4.91B | 4.47B | 4.20B | 4.04B | 4.05B |
| Net Income | 1.30B | 1.29B | 1.24B | 1.25B | 1.21B | 719.00M | 1.07B | 316.00M | 684.00M | 460.00M | 401.00M | 549.00M |
| EPS | 4.59 | 4.44 | 4.22 | 4.19 | 3.98 | 2.33 | 3.41 | 0.98 | 2.12 | 1.42 | 1.20 | 1.65 |
| Total Assets | 12.73B | 11.85B | 10.76B | 10.53B | 10.71B | 9.63B | 9.45B | 8.54B | 8.43B | 7.79B | 7.48B | 10.81B |
| Total Debt | 3.35B | 3.57B | 2.73B | 2.77B | 2.73B | 2.36B | 2.41B | 1.80B | 2.01B | 1.90B | 1.66B | 1.66B |
| Cash & Equivalents | 1.79B | 1.33B | 1.59B | 1.05B | 1.48B | 1.44B | 1.38B | 2.25B | 2.68B | 2.29B | 2.00B | 2.22B |
| Operating Cash Flow | 1.56B | 1.75B | 1.77B | 1.31B | 1.49B | 921.00M | 1.02B | 1.09B | 889.00M | 793.00M | 491.00M | 713.00M |
| Free Cash Flow | 1.15B | 1.37B | 1.47B | 1.02B | 1.30B | 802.00M | 865.00M | 910.00M | 713.00M | 654.00M | 393.00M | 506.00M |
| FCF per Share | 4.07 | 4.73 | 5.01 | 3.41 | 4.26 | 2.60 | 2.75 | 2.83 | 2.21 | 2.01 | 1.18 | 1.52 |
| Book Value | 6.74B | 5.90B | 5.84B | 5.30B | 5.39B | 4.87B | 4.75B | 4.57B | 4.83B | 4.24B | 4.16B | 5.30B |
| Cash & ST Investments | 1.79B | 1.33B | 1.59B | 1.05B | 1.57B | 1.44B | 1.38B | 2.25B | 2.68B | 2.29B | 2.00B | 2.22B |
| ROC Equity | 0.19 | 0.22 | 0.21 | 0.24 | 0.22 | 0.15 | 0.23 | 0.07 | 0.14 | 0.11 | 0.10 | 0.10 |